MALDI-TOF Mass Spectrometry-Based Assay for Measuring Covalent Target Engagement of KRAS G12C Inhibitors
Authors:
- 4 April 2024
- book chapter
- Published by Springer Nature
- Vol. 2797, 145-157
Abstract
MALDI-TOF mass spectrometry enables high-throughput screening of covalent fragment libraries and SAR compound progressions of selective KRAS G12C inhibitors. Using the MALDI-TOF platform instead of the more traditional ESI-MS TOF/orbitrap instrumentation can radically shorten sample acquisition time, allowing up to 384 samples to be screened in 30 min. The typical throughput for a covalent library screen is 1152 samples per 8 h, including processing, calculation, and reporting steps. The throughput can be doubled without any significant assay modification. Key words MALDI-TOF MS High-throughput screening Covalent screening Fragment-based screening RAS covalent inhibitors KRAS G12C Sotorasib AdagrasibKeywords
This publication has 14 references indexed in Scilit:
- Covalent fragment mapping of KRasG12C revealed novel chemotypes with in vivo potencyEuropean Journal of Medicinal Chemistry, 2023
- KRAS G12C fragment screening renders new binding pocketsSmall GTPases, 2021
- Acquired Resistance to KRAS G12C Inhibition in CancerNew England Journal of Medicine, 2021
- Identification of the Clinical Development Candidate MRTX849, a Covalent KRASG12C Inhibitor for the Treatment of CancerJournal of Medicinal Chemistry, 2020
- Recent Advances in Selective and Irreversible Covalent Ligand Development and ValidationCell Chemical Biology, 2019
- The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunityNature, 2019
- Chemical Proteomic Characterization of a Covalent KRASG12C InhibitorACS Medicinal Chemistry Letters, 2018
- Direct small-molecule inhibitors of KRAS: from structural insights to mechanism-based designNature Reviews Drug Discovery, 2016
- Quantitative determination of the Ru(bpy)32+ cation in photochemical reactions by matrix-assisted laser desorption/ionization time-of-flight mass spectrometryAnalytical Methods, 2014
- K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactionsNature, 2013